Internal Medicine, Hematology & Oncology · Cleveland, OH
NPI
1104203645
Since 2015
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
10201 Carnegie Ave
Cleveland, OH, 44106
Phone (662) 238-1008
Groups this clinician bills Medicare through
Medicare paid, 2024
$24K
297 services
Medicare patients, 2024
119
Average age 70
Drug cost, 2024
$1.8M
581 prescriptions
Company payments, 2025
$9,999
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Azka Ali was code 99215 (office e&m - established), 63 times for 35 patients. In total Azka Ali billed 297 services in 18 codes, and Medicare paid $24K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 63 | 35 | $108.85 | $6,857 |
| 99213 Office E&M - Established | Facility | 38 | 30 | $48.37 | $1,838 |
| 99233 Hospital E&M - Subsequent | Facility | 38 | 20 | $80.94 | $3,076 |
| 99214 Office E&M - Established | Facility | 20 | 15 | $51.29 | $1,026 |
| 99213 Office E&M - Established | Office | 16 | 14 | $66.77 | $1,068 |
| 99232 Hospital E&M - Subsequent | Facility | 16 | 12 | $59.04 | $945 |
| 99205 Office E&M - New | Facility | 14 | 14 | $137.40 | $1,924 |
| 99223 Hospital E&M - Initial | Facility | 11 | 11 | $121.03 | $1,331 |
By year: 2022 $8,984 for 100 services; 2023 $28K for 332 services; 2024 $24K for 297 services.
Medicare prescription drug claims, 2024
In 2024, the drug Azka Ali prescribed most often to Medicare patients was Anastrozole, with 172 prescriptions and refills. In total Azka Ali wrote 581 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 172 | 437 | 60 | $2,896 |
| Letrozole Generic | 50 | 127 | 20 | $1,988 |
| Kisqali Ribociclib Succinate | 44 | 44 | Under 11 | $711K |
| Verzenio Abemaciclib | 38 | 38 | Under 11 | $592K |
| Gabapentin Generic | 25 | 25 | Under 11 | $112 |
| Prochlorperazine Maleate Generic | 17 | 17 | Under 11 | $128 |
| Tamoxifen Citrate Generic | 16 | 46 | Under 11 | $677 |
| Phesgo Pertuzumab-Trastuzumab-Hy-Zzxf | 15 | 15 | Under 11 | $132K |
| Ondansetron Hcl Generic | 13 | 13 | Under 11 | $280 |
| Colestipol Hcl Generic | 12 | 12 | Under 11 | $423 |
| Exemestane Generic | 11 | 13 | Under 11 | $634 |
Brand drugs: - claims; generic drugs: 445 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Azka Ali $9,999 ($9,999 in general payments such as food, travel and fees) from 6 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $6,637.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.